Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biote Corp. - Class A common stock (NQ: BTMD )

6.250 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.250
Bid (Size) 2.500 (2)
Ask (Size) 9.930 (1)
Prev. Close 6.250
Today's Range 6.250 - 6.250
52wk Range 3.654 - 8.440
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q2 2024
BTMD stock results show that Biote missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Biote Reports Second Quarter 2024 Financial Results
From biote Corp.
Via Business Wire

Performance

YTD
+32.14%
+32.14%
1 Month
-19.67%
-19.67%
3 Month
-4.73%
-4.73%
6 Month
+5.04%
+5.04%
1 Year
+26.77%
+26.77%

More News

Read More
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
From biote Corp.
Via Business Wire
Biote: Q4 Earnings Insights
Via Benzinga
Preview: Biote's Earnings
Via Benzinga
BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Biote Reports First Quarter 2024 Financial Results
From Biote
Via Business Wire
Biote Announces Definitive Settlement with Founder
From biote Corp.
Via Business Wire
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
From Biote
Via Business Wire
Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call
From Biote Corp.
Via Business Wire
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
From biote Corp.
Via Business Wire
Earnings Scheduled For March 12, 2024
Via Benzinga
Biote Announces $20 Million Share Repurchase Authorization
From biote Corp.
Via Business Wire
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
From biote Corp.
Via Business Wire
Biote to Purchase Asteria Health
From biote Corp.
Via Business Wire
Biote Names Robert Peterson as Chief Financial Officer
From biote Corp.
Via Business Wire
Biote Reports Third Quarter 2023 Financial Results
From Biote
Via Business Wire
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Biote Reports Second Quarter 2023 Financial Results
From Biote
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.